Trial Profile
Platelet Reactivity After Switching from Clopidogrel to Prasugrel in Patients with Coronary Artery Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Nov 2015
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary)
- Indications Coronary artery disease; Ischaemic heart disorders
- Focus Therapeutic Use
- 15 Nov 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 15 Jul 2014 New trial record